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A series of five related publications describe an alternative pluripotent state that is dependent on continuous
high levels of exogenous reprogramming factor expression. A comprehensive effort to molecularly compare
the acquisition of this state to induced pluripotency aims at providing new insights into the mechanisms
underlying cellular reprogramming.The ectopic expression of transcription
factors (TFs) associated with the embry-
onic state in somatic cells affords re-
searchers an accessible source of plurip-
otent stem cells. The question of how TFs
achieve this remarkable conversion has
fueled increasingly sophisticated ana-
lyses of reprogramming intermediates
(Papp and Plath, 2013). While aspects of
the reprogramming process—such as
the starting somatic cell type, reprogram-
ming factor stoichiometry, and culture
conditions—can influence the properties
of induced pluripotent stem cells (iPSCs),
it is generally assumed that reprogram-
ming yields stem cell lines that are highly
similar to each other. In fact, the desire
to generate iPSCs that are as close as
possible to fertilization-derived embry-
onic stem cells (ESCs) has been a driving
force behind iPSC research ever since the
discovery of induced pluripotency. In a
series of noteworthy publications (Benev-
ento et al., 2014; Clancy et al., 2014; Hus-
sein et al., 2014; Lee et al., 2014; Tonge
et al., 2014), a consortium of international
research teams challenges the notion of a
singular end-point of reprogramming and
takes an ambitious approach to under-
stand an alternative pluripotent state and
its acquisition.
Using an inducible transposon system,
Andras Nagy and colleagues from the
University of Toronto report in Nature
that very high (5- to 100-fold of the levels
seen in ESCs) and persistent expression
of the ‘‘Yamanaka factors’’ Oct4, Klf4,
Sox2, and c-Myc (OKSM) in mouse fibro-
blasts reproducibly establish a pluripotent
state that is different from that of conven-tional iPSCs in several aspects (Tonge
et al., 2014) (Figure 1). Cells generated in
this manner—referred to as F-class cells
due to the fuzzy borders of colonies ob-
tained—express Nanog and endogenous
Oct4, but not most other ESC-associated
genes. Instead, F-class cells express high
levels of genes associated with cell fate
commitment, suggesting that they are
primed for differentiation. Additional note-
worthy features of these cells are an ultra-
fast cell cycle transition, the capacity to
grow in absence of leukemia inhibitory
factor (LIF), and the propensity to not
aggregate in suspension culture. Maybe
most importantly, F-class cells require
continuous high levels of exogenous
OKSM for their propagation, thereby devi-
ating from the concept of transgene inde-
pendence that has been established as a
hallmark of induced pluripotency. Never-
theless, upon shutdown of exogenous
factors, F-class cells appear to undergo
multilineage differentiation in vitro and
in the context of teratomas, but they fail
in stricter pluripotency assays such as
chimera formation. Intriguingly, F-class
cells treated with histone deacetylase in-
hibitors convert into transgene-indepen-
dent cells similar to ESCs that are capable
of germline transmission within days of
treatment (Tonge et al., 2014). This transi-
tion suggests that F-class reprogramming
does not negatively impact upon genomic
integrity.
Formation of F-class cells normally re-
quires 2–3 weeks of high levels of OKSM
expression, representing conditions un-
der which iPSCs form very infrequently.
However, when exogenous OKSM levelsCell Stem Celare experimentally lowered at an arbitrary
point during reprogramming, fully pluripo-
tent transgene-independent cell lines
appear more frequently. In a second pa-
per in Nature, the same group exploits
this observation to conduct an exception-
ally deep analysis of the transcriptome,
proteome, and epigenome of bulk cell
populations at various points along these
two routes to pluripotency (Hussein et al.,
2014). In addition, three papers in Nature
Communications dissect in great detail
specific aspects of F-class and iPSC
reprogramming, in particular dynamic
changes of small RNAs (Clancy et al.,
2014), protein abundance (Benevento
et al., 2014), and DNA methylation (Lee
et al., 2014). Fittingly, the authors refer
to their combined efforts as Project
Grandiose. A corresponding online portal
(http://www.stemformatics.org) will be a
versatile resource for future research into
the biology of reprogramming.
The authors’ own analyses largely
confirm previous genome-wide studies of
prospectively isolated reprogramming in-
termediates and ‘‘pre-iPSC’’ lines (Koche
et al., 2011; Polo et al., 2012), although
a number of molecular differences exist
that might be explained by the particular-
ities of their reprogramming system. This
includes the rapid and global disappear-
ance of the repressive H3K27me3 histone
mark upon OKSM expression, which is
reacquired during the transition to the
F-state. DNA methylation at somatic loci
occurs gradually during both F-class and
iPSC reprogramming,while demethylation
of ESC-associated loci is impaired in the
F-class trajectory (Hussein et al., 2014).l 16, January 8, 2015 ª2015 Elsevier Inc. 9
Figure 1. Illustration of the Reprogramming Routes Leading to Conventional iPSCs and
Newly Discovered F-Class Cells
Note the importance of different levels of Oct4, Klf4, Sox2, and c-Myc (OKSM) expression. Key cellular and
functional differences of the two cell types are shown on the right (see the text for molecular differences).
F-class cells can be converted into iPSCs by exposure to histone deacetylase inhibitors (HDACi), while at
least some F-class features can be established in iPSCs by high OKSM levels in the presence of Janus
kinase inhibitors (JAKi) and the absence of leukemia inhibitory factors (LIF).
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the intriguing discovery of new protein-
coding transcripts and unexpected layers
of post-transcriptional gene regulation,
such as intron retention for many highly
transcribed genes in the F-state (Hussein
et al., 2014).
The description of an alternative, albeit
transgene-dependent, pluripotent state
is provocative and raises several ques-
tions. For example, can additional plurip-
otent states be obtained upon expression
of OKSM or other factor combinations
able to drive iPSC formation? Of note,
Tonge et al. themselves mention the gen-
eration of a second class of cells with
similar morphology but different gene
expression from that of ESCs (referred
to as C-class) in high OKSM conditions.
Determining DNA occupancy of reprog-
ramming factors likely will shed light on
why alternative types of pluripotent cells
emerge, as it has for iPSC reprogramming
(Papp and Plath, 2013). The observation10 Cell Stem Cell 16, January 8, 2015 ª2015that many ESC-associated genes remain
silent in F-class cells points toward a
repressive role of OKSM when expressed
at high levels, which supports a docu-
mented inhibitory effect of these factors
on iPSC formation late in reprogramming
(Golipour et al., 2012). Histone deacety-
lase inhibitors can overcome this repres-
sion, raising the question of whether
OKSM in F-class cells interacts with the
same repressive complexes that have
been proposed to constitute reprogram-
ming roadblocks (Rais et al., 2013).
Will some of the unique properties of
F-class cells facilitate the use of pluripo-
tent cells in downstream applications?
Because mouse pluripotent cells can
be easily and quickly expanded to large
numbers, the ultrafast cycling time of F-
class cells may not be all too relevant for
practical purposes. Thismight be different
if human F-class cells with similar prop-
erties are discovered. As suggested by
Tongeet al., thepropensity of F-class cellsElsevier Inc.to not aggregate in suspension culture
opens up the possibility of large-scale
expansion in stirring incubators. However,
it remains to be seen whether this partic-
ular F-class feature is compatible with
differentiation protocols that require the
formation of embryoid bodies as an inter-
mediate step. As it is, the discovery of F-
class cells offers a new and conceptually
stimulating approach to study transcrip-
tion-factor-induced pluripotency.REFERENCES
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